Similar articles

• [Value of the analysis of DNA cellular content by flow cytometry in Barrett esophagus].

  Robaszkiewicz M, Hardy E, Volant A. Robaszkiewicz M, et al. Gastroenterol Clin Biol. 1994;18(1 Pt 2):D35-9. Gastroenterol Clin Biol. 1994. PMID: 8013781 Review. French. No abstract available.
• Progression to cancer in Barrett's esophagus is associated with genomic instability.

  Rabinovitch PS, Reid BJ, Haggitt RC, Norwood TH, Rubin CE. Rabinovitch PS, et al. Lab Invest. 1989 Jan;60(1):65-71. Lab Invest. 1989. PMID: 2911184
• p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.

  Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C. Bian YS, et al. Mod Pathol. 2001 May;14(5):397-403. doi: 10.1038/modpathol.3880324. Mod Pathol. 2001. PMID: 11353048
• Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.

  Krishnadath KK, Tilanus HW, Alers JC, Mulder AH, van Dekken H. Krishnadath KK, et al. Cytometry. 1994 Feb 1;15(2):176-84. doi: 10.1002/cyto.990150212. Cytometry. 1994. PMID: 8168405
• Prognostic value of p53 in Barrett's oesophagus.

  Krishnadath KK, van Blankenstein M, Tilanus HW. Krishnadath KK, et al. Eur J Gastroenterol Hepatol. 1995 Jan;7(1):81-4. Eur J Gastroenterol Hepatol. 1995. PMID: 7866817 Review.